Zobrazeno 1 - 10
of 38
pro vyhledávání: '"C. Ritleng"'
Autor:
Eric Van Ganse, G. Desamericq, Gisele Bauguil, Anne Revol, Laurent Laforest, C. Ritleng, Geneviève Chamba
Publikováno v:
Therapies. 64:395-403
Resume Objectif Decrire les caracteristiques et la prise en charge de patients migraineux suivis medicalement en officines. Methodes Des questionnaires et des historiques medicamenteux ont permis de rassembler des informations sur les migraines, la c
Autor:
Philippe Le Jeunne, Liesl Osman, C. Ritleng, Abdelkader El Hasnaoui, Marie-Sophie Schwalm, Laurent Laforest, Céline Pribil, Eric Van Ganse
Publikováno v:
Respiratory Medicine. 103:1366-1375
Summary Background Patient adherence to recommended use of ICS is questionable in asthma, with irregular use or interruptions occurring frequently. Factors explaining discontinuation of controller therapy could orientate interventions. The characteri
Autor:
Céline Pribil, C. Ritleng, Laurent Laforest, Eric Van Ganse, Marie-Sophie Schwalm, Abdelkader El Hasnaoui
Publikováno v:
ResearcherID
Background Patients' perception of their ability to influence their asthma symptoms has not been sufficiently addressed. Objective To study the relationship between patients' perceived ability to self-care, as approached by internal locus of control
Autor:
Romain Marignier, E. Van Ganse, C. Ritleng, Sandra Vukusic, Françoise Durand-Dubief, Laurent Laforest, Cyrille B. Confavreux, Marc Debouverie, Géraldine Androdias
Publikováno v:
Multiple Sclerosis Journal. 14:1144-1147
Autor:
Gérard Chatté, F. Denis, Laurent Laforest, Gilles Devouassoux, C. Ritleng, Nathalie Freymond, Christel Saussier, Nadine Passante, Eric Van Ganse, Yves Pacheco
Publikováno v:
Primary Care Respiratory Journal: Journal of the General Practice Airways Group
Primary Care Respiratory Journal: Journal of the General Practice Airways Group, 2010, 19 (2), pp.148--154. ⟨10.4104/pcrj.2010.00004⟩
Primary Care Respiratory Journal: Journal of the General Practice Airways Group, 2010, 19 (2), pp.148--154. ⟨10.4104/pcrj.2010.00004⟩
International audience; AIMS: To identify the correlates of accidental omissions and intentional interruptions of respiratory therapy in COPD. METHODS: COPD patients (GOLD stages II-IV) were recruited by general practitioners or respiratory physician
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae48b1610f5d8bb185e3b827fe848f9
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01838988
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01838988
Autor:
B. Fontaine, Bruno Brochet, Giovanni Castelnovo, F. Borgel, Maya Tchikviladzé, David Brassat, Gilles Edan, Nicolas Collongues, M. Milh, P. Tourniaire, Frédéric Blanc, William Camu, Eric Thouvenot, Romain Marignier, Sandrine Wiertlewski, Michel Clanet, J Grimaud, Jean Pelletier, Alain Créange, Marie-Céline Fleury, Marc Debouverie, E. Le Page, Diana Rodriguez, Cyrille B. Confavreux, J. de Seze, Olivier Gout, Olivier Outteryck, Pierre Labauge, Olivier Heinzlef, Caroline Papeix, B. Barroso, David-Axel Laplaud, Bertrand Audoin, Hélène Zéphir, Thibault Moreau, Sandra Vukusic, Gilles-Louis Defer, Christine Lebrun-Frenay, Patrick Vermersch, C. Ritleng, Aurélie Ruet
Publikováno v:
ResearcherID
Background: There have been few epidemiologic studies on neuromyelitis optica (NMO) and none used the recent 2006 diagnostic criteria. Here we describe the clinical, laboratory, MRI, and disability course of NMO in a French cohort of 125 patients. Me
Autor:
C. Ritleng, Eric Van Ganse, Marie-Sophie Schwalm, Laurent Laforest, T. Souchet, G. Desamericq, Philippe Le Jeunne, Philippe Moulin
Publikováno v:
Archives of cardiovascular diseases
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2009, 102 (1), pp.43--50. ⟨10.1016/j.acvd.2008.06.021⟩
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2009, 102 (1), pp.43--50. ⟨10.1016/j.acvd.2008.06.021⟩
International audience; AIM: To estimate the prevalence of triglyceride and/or high density lipoprotein cholesterol (HDL-C) disorders and their relationships with other cardiovascular risk factors among patients with dyslipidaemia on lipid-lowering t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85a526ecc0d1249458f833043c64237b
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01838989
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01838989
Autor:
Hubert Mechin, Alain Moreau, Sarah Rosen, G. Desamericq, Laurent Laforest, Geneviève Chamba, Laurent Letrilliart, Eric Van Ganse, C. Ritleng
Publikováno v:
BMC Public Health
BMC Public Health, BioMed Central, 2009, 9, pp.337. ⟨10.1186/1471-2458-9-337⟩
BMC Public Health, Vol 9, Iss 1, p 337 (2009)
BMC Public Health, 2009, 9, pp.337. ⟨10.1186/1471-2458-9-337⟩
BMC Public Health, BioMed Central, 2009, 9, pp.337. ⟨10.1186/1471-2458-9-337⟩
BMC Public Health, Vol 9, Iss 1, p 337 (2009)
BMC Public Health, 2009, 9, pp.337. ⟨10.1186/1471-2458-9-337⟩
Background The correlates of quality of life (QOL), as measured by the OSQOL questionnaire were investigated in a convenience sample of overweight patients recruited in pharmacies. Methods A convenience sample of patients with a Body Mass Index ≥ 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8925e3f0d4b6205bdfcf07dc46ad5222
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01838992
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01838992
Autor:
T. Souchet, Alexia Kieffer, Marie-Sophie Schwalm, Laurent Laforest, Philippe Moulin, Philippe Le Jeunne, C. Ritleng, G. Desamericq, Eric Van Ganse
Publikováno v:
Atherosclerosis
Atherosclerosis, 2008, 199 (2), pp.368--377. ⟨10.1016/j.atherosclerosis.2007.11.033⟩
Atherosclerosis, 2008, 199 (2), pp.368--377. ⟨10.1016/j.atherosclerosis.2007.11.033⟩
International audience; BACKGROUND: LDL-cholesterol therapeutic objectives attainment under lipid lowering therapy remains inadequate. The correlates of LDL-cholesterol therapeutic objective attainment have not been thoroughly explored in an observat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3e9882af2b782358b5133fb45352f5e
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01838993
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01838993
Autor:
L. Laforest, Cyrille B. Confavreux, Michel Clanet, F. Rocher, N. Passante, C. Ritleng, Sandra Vukusic, A. Castot, E. Van Ganse
Publikováno v:
BMJ Quality & Safety. 19:A179-A180
Background Natalizumab, a monoclonal antibody, has shown efficacy in reducing the relapse rate and delaying disability accumulation in relapsing remitting (RR) multiple sclerosis (MS) patients. However, severe opportunistic infections and infusion re